Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Aug;95(8):1632-1648.
doi: 10.1016/j.mayocp.2020.06.003. Epub 2020 Jun 10.

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis

Raseen Tariq  1 , Srishti Saha  2 , Fateeha Furqan  3 , Leslie Hassett  4 , Darrell Pardi  2 , Sahil Khanna  5
Affiliations
Meta-Analysis

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis

Raseen Tariq et al. Mayo Clin Proc. 2020 Aug.

Abstract

Objective: To perform a systematic review and meta-analysis evaluating the prevalence of gastrointestinal (GI) symptoms and mortality in patients with coronavirus disease 2019 (COVID-19) diagnosed.

Methods: A systematic search of MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus was performed from December 1, 2019 to May 7, 2020. Observational studies including adults with COVID-19 infection and reporting GI symptoms were included. The primary outcome was assessing the weighted pooled prevalence (WPP) of GI symptoms in patients with COVID-19 infection. Secondary outcomes were WPP of overall mortality, and mortality in patients with COVID-19 infection with GI symptoms.

Results: A total of 78 studies with 12,797 patients were included. Among GI symptoms (at onset of illness in 6, at admission in 17, data given separately for both in 3, and data unavailable in 52 studies), the WPP of diarrhea was 12.4% (95% CI, 8.2% to 17.1%), I2=94%; nausea and/or vomiting, 9.0% (95% CI, 5.5% to 12.9%), I2=93%; loss of appetite, 22.3% (95% CI, 11.2% to 34.6%, I2=94%; and abdominal pain, 6.2% (95% CI, 2.6% to 10.3%), I2=92%. Mortality among patients with GI symptoms (0.4%; 95% CI, 0% to 1.1%; I2=74%) was similar to overall mortality (2.1%; 95% CI, 0.2% to 4.7%; I2=94%), P=.15. Most studies had high risk of bias and overall quality of evidence was low to very low for all outcomes.

Conclusion: Gastrointestinal symptoms are seen in up to 1 in 5 patients with COVID-19 infection. More high-quality evidence is needed to confirm these findings and explore factors causing mortality in these patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of study selection process.
Figure 2
Figure 2
Forest plot shows weighted pooled prevalence (Prev) of diarrhea in patients with coronavirus disease 2019 infection. C-NERC = COVID National Emergency Response Center; C-NIRST = Coronavirus Disease 2019 National Incident Room Surveillance Team; Q = Cochrane's Q test.
Figure 2
Figure 2
Forest plot shows weighted pooled prevalence (Prev) of diarrhea in patients with coronavirus disease 2019 infection. C-NERC = COVID National Emergency Response Center; C-NIRST = Coronavirus Disease 2019 National Incident Room Surveillance Team; Q = Cochrane's Q test.
Figure 3
Figure 3
Forest plot shows weighted pooled rate of overall mortality in coronavirus disease 2019 infection. C-NIRST = Coronavirus Disease 2019 National Incident Room Surveillance Team; Prev = prevalence; Q = Cochrane's Q test.
Figure 4
Figure 4
Forest plot shows weighted pooled rate of mortality in coronavirus disease 2019 infection with gastrointestinal (GI) symptoms. Prev = prevalence; Q = Cochrane's Q test.
See this image and copyright information in PMC

Comment in

References

    1. World Health Organization Coronavirus disease 2019 (COVID-19): situation report-121. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Accessed May 21, 2020.
    1. Johns Hopkins University of Medicine, Coronavirus Resource Center. COVID-19 case tracker. 2020. https://coronavirus.jhu.edu/ Accessed May 21, 2020.
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. [published online ahead of print February 24, 2020]. JAMA. - DOI - PubMed
    1. Luo S., Zhang X., Xu H. Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) Clin Gastroenterol Hepatol. 2020;18(7):1636–1637. - PMC - PubMed
    1. Cheung K.S., Hung I.F., Chan P.P. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. [published online ahead of print April 3, 2020]. Gastroenterology. - DOI - PMC - PubMed